The 340B PATIENTS Act of 2024

About

This legislation would:

Clarify that manufacturers are required to offer 340B discount prices to covered entities regardless of the manner or location in which a drug is dispensed, including if a covered entity uses a contract pharmacy to dispense 340B drugs to the entity’s patients.
Ensure that manufacturers cannot place conditions on the ability of a covered entity to purchase and use 340B drugs, regardless of the manner or location in which the drug is dispensed, including through contract pharmacies.
Impose civil monetary penalties on manufacturers that violate these statutory requirements and prohibitions.

See Full Bill

Quick Facts